XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.3
INTANGIBLE ASSETS
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS INTANGIBLE ASSETS
Intangible assets consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands):
 September 30, 2023December 31, 2022
GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Goodwill(1)
$33,237 $— $33,237 $33,237 $— $33,237 
Indefinite-lived intangible assets:
Trade names(1)
49,600 — 49,600 49,600 — 49,600 
Finite-lived intangible assets:
Licenses15,847 (11,996)3,851 15,847 (11,654)4,193 
Trade names(2)
54,802 (22,790)32,012 54,785 (20,030)34,755 
Customer relationships(2)
143,157 (61,119)82,038 143,157 (53,586)89,571 
Other (2)
5,858 (3,724)2,134 5,856 (3,325)2,531 
Total$302,501 $(99,629)$202,872 $302,482 $(88,595)$213,887 
(1)The gross and net value at September 30, 2023 and December 31, 2022 reflect a reduction of $91.7 million in impairment charges on goodwill and $1.0 million in impairment charges on indefinite-lived intangible assets.
(2)The gross value and accumulated amortization at September 30, 2023 reflect a reduction of $44.1 million and $(29.3) million, respectively, for the net $14.8 million previous impairment charge on finite-lived intangible assets within the international segment and a $6.5 million reduction in gross value for previous impairment charges on finite-lived intangible assets within the U.S. segment.
In the third quarter of 2023, the Company observed a sustained decline in the market valuation of the Company's common stock over a twelve month period and an increase in the risk free interest rate. Based on these factors and considering the limited excess fair value over carrying value observed in the last annual impairment test on October 1, 2022, the Company concluded that a triggering event had occurred and performed an interim impairment test of goodwill and certain intangible assets as of September 30, 2023.
Goodwill
The Company performed an interim impairment test of the goodwill in the U.S. reporting unit by comparing its fair value with its carrying value. The analysis was performed by using a discounted cash flow and market multiple method. Based upon the analysis performed, the Company determined that the fair value of the Company's U.S. reporting unit exceeded its carrying value, and therefore goodwill was not impaired. As of September 30, 2023, the fair value of the U.S. reporting unit exceeded the carrying value of goodwill by 4%.
Indefinite-lived trade names
The Company performed an interim quantitative impairment analysis of its indefinite-lived trade names by comparing the fair value of the indefinite-lived trade names to their respective carrying values. The Company values its indefinite-lived trade names using a relief-from-royalty approach, which assumes the value of the trade name is the discounted cash flows of the amount that would be paid by a hypothetical market participant had they not owned the trade name and instead licensed the trade name from another company. The Company determined that the fair value of all its indefinite-lived trade names were above their respective carrying values, and therefore its indefinite-lived intangible assets were not impaired. In connection with the interim impairment analysis, the Company determined that one trade name, previously estimated to contribute to cash flows indefinitely, has a definite life. Accordingly, the trade name will be reclassified from indefinite-lived to finite-lived or amortizable intangible assets as of October 1, 2023. The trade name will be amortized over an estimated useful life of 15 years. As of September 30, 2023, the fair value of the Company’s indefinite-lived trade name exceeded the respective carrying value by 7%.